患有急性冠状动脉综合征的患者的死亡率 - 一项前性5年随访研究
Thuy Mi Nguyen1,2,3, Daniela Melichova1,2,3, Eivind W Aabel2,3
1Department of Cardiology, Hospital of Southern of Norway, 4604 Kristiansand, Norway.
Journal of clinical medicine
|October 28, 2023
概括
十年来,非ST升高心肌梗塞 (NSTEMI) 的死亡率保持不变. 然而,ST升高心肌梗塞 (STEMI) 患者的死亡率显著降低,与更快的冠状动脉血管造影时间有关.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- 关于心肌梗塞 (MI) 重血管化后的长期结果的当代数据有限.
- 随着时间的推移,非ST升高MI (NSTEMI) 和ST升高MI (STEMI) 之间的结果比较对于评估治疗进展至关重要.
- 挪威南部为这一比较分析提供了一个特定的区域背景.
研究的目的:
- 为了比较NSTEMI和STEMI患者的长期结果,特别是全因死亡率.
- 为了评估死亡率和冠状动脉血管造影的时间在两个不同的治疗期间 (2004-2009年和2014-2015年) 之间的变化.
- 评估治疗演变对急性心肌梗塞 (AMI) 患者十年来治疗结果的影响.
主要方法:
- 预期的后续研究设计.
- 包括两个时间段连续的NSTEMI和STEMI患者:2004-2009年和2014-2015年.
- 对所有原因死亡率的初级结局进行5年的随访,在MI后的1年和5年.
主要成果:
- 对于NSTEMI患者的死亡率保持稳定:1年 (3.5%与4.9%,p=0.50) 和5年 (11.4%与14.6%,p=0.40).
- 在后期,STEMI患者的1年死亡率 (1.3%对11.1%,p<0.001) 和5年死亡率 (7.0%对22.2%,p=0.004) 显著降低.
- 在STEMI患者中,冠状动脉血管造影的时间显著改善 (2.8h vs. 21.7h,p<0.001),而在NSTEMI患者中,时间保持不变 (28.2h vs. 30.3h,p=0.20).
结论:
- 尽管十年来急性心肌梗塞 (AMI) 治疗方面取得了进展,但NSTEMI患者的死亡率并未改善.
- 在STEMI患者的长期结果中观察到显著的改善,与冠状动脉血管造影的时间缩短相关.
- 这些发现凸显了NSTEMI和STEMI之间治疗结果演变的差异,强调了对NSTEMI的持续研究和优化护理途径的需要.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.3K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.5K
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
01:26Acute Coronary Syndrome V: Nursing Management
16
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
01:30Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
01:28Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
19
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
19
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9